Cocrystal Pharma Inc. Stock
Cocrystal Pharma Inc. Stock
A very strong showing by Cocrystal Pharma Inc. today, with an increase of €0.025 (3.130%) compared to yesterday's price.
The community is currently still undecided about Cocrystal Pharma Inc. with 1 Buy predictions and 0 Sell predictions.
With a target price of 5 € there is potential for a 506.06% increase which would mean more than doubling the current price of 0.83 € for Cocrystal Pharma Inc..
Our community identified positive and negative aspects for Cocrystal Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Cocrystal Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Cocrystal Pharma Inc. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
B****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cocrystal Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cocrystal Pharma Inc. | 3.130% | 9.091% | -2.890% | -52.000% | 3.067% | -54.298% | -94.928% |
| Rockwell Medical Inc. | -1.200% | -9.924% | -19.426% | -53.636% | 14.043% | -61.425% | -94.155% |
| Pacira Pharmaceuticals | -5.030% | -1.042% | 9.195% | -20.833% | -12.037% | -50.777% | -68.333% |
| Twist Bioscience Corp | 0.120% | -7.623% | 13.374% | 4.755% | 47.935% | 126.772% | -64.786% |
Comments
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $7.00 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $10.00 to $7.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat